MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First
POSTS IN CATEGORY
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First
hospitalThammasat Rangsit “Kanchana” visits a 3-year-old child who was physically assaulted. Surgery is safe,
More newborn in remote areas of Ilocos Norte no longer need to be traveled
Oil companies have announced a decrease of up to PHP1.10 per liter in the